Combined gene therapy and ionizing radiation is a novel approach to treat human esophageal adenocarcinoma

Annals of Surgical Oncology

Volumn 9, Issue 5, 2002, Pages 500-504

  Gupta, Vinay K ^a   Park, James O ^a   Jackowiak, Nora T ^a   Mauceri, Helena J ^a   Seetharam, Saraswathy ^a   Weichselbaum, Ralph R ^a   Posner, Mitchell C ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Esophageal cancer; Gene therapy; Ionizing radiation; Tumor necrosis factor

Indexed keywords

ADENOVIRUS VECTOR; COMPLEMENTARY DNA; EARLY GROWTH RESPONSE FACTOR 1; TUMOR NECROSIS FACTOR ALPHA;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CANCER CELL; CANCER INHIBITION; CANCER RADIOTHERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ESOPHAGUS CARCINOMA; GENE THERAPY; HUMAN; HUMAN CELL; IONIZING RADIATION; MOUSE; NONHUMAN; NUDE MOUSE; TUMOR GROWTH; XENOGRAFT;

ADENOCARCINOMA; ADENOVIRIDAE; ANIMALS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENETIC VECTORS; HUMANS; IMMEDIATE-EARLY PROTEINS; MICE; MICE, NUDE; PROMOTER REGIONS (GENETICS); RADIOTHERAPY; TRANSCRIPTION FACTORS; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036279829     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/aso.2002.9.5.500     Document Type: Article

References (24)

1. Incidence, epidemiology, and etiology of esophageal cancer
2. The changing epidemiology of esophageal cancer
3. Changing trends in esophageal cancer: A 15-year experience in a single center
4. Management of esophageal cancer
5. Combined modality therapy for esophageal cancer
6. Neoadjuvant therapy of esophageal cancer
7. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma
8. Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01)
9. Multidisciplinary approach to esophageal and gastric cancer
10. Optimal treatment for localized esophageal cancer still uncertain
11. Antiproliferative effects exerted by recombinant human tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) on human pancreatic tumor cell lines
12. Synergistic induction of apoptosis in murine hepatoma Hepal-6 cells by IFN-gamma and TNF-alpha
13. Interaction of tumour necrosis factor-alpha and radiation against human colon tumour cells
14. Tumor necrosis factor alpha augments radiation effects against human colon tumor xeno-grafts
15. A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients
16. Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic study
17. Gene therapy targeted by radiation preferentially radiosensitizes tumor cells
18. Principles of gene therapy: Cancer gene therapy
19. A radiation-controlled molecular switch for use in gene therapy of cancer
20. Radiation-inducible gene therapy
21. Early transcriptional events in cell growth: The Egr family
22. A gene encoding a protein with zinc fingers is activated during G0/G1 transition in cultured cells
23. Protein kinase C mediates x-ray inducibility of nuclear signal transducers EGR1 and JUN
24. Spatial and temporal control of gene therapy using ionizing radiation